Sameer Melinkeri

1.0k total citations
24 papers, 221 citations indexed

About

Sameer Melinkeri is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Sameer Melinkeri has authored 24 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Sameer Melinkeri's work include Platelet Disorders and Treatments (3 papers), Immunotherapy and Immune Responses (3 papers) and Blood groups and transfusion (3 papers). Sameer Melinkeri is often cited by papers focused on Platelet Disorders and Treatments (3 papers), Immunotherapy and Immune Responses (3 papers) and Blood groups and transfusion (3 papers). Sameer Melinkeri collaborates with scholars based in India and United States. Sameer Melinkeri's co-authors include Vaijayanti Kale, Lalita Limaye, Sunil Dabadghao, Ruchi Gupta, Saroj Kanta Mishra, Joseph Philip, Manas Kumar Santra, Vikram Mathews, Shashikant Apte and Kavitha M. Lakshmi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Sameer Melinkeri

23 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sameer Melinkeri India 9 81 66 62 58 32 24 221
Nobuya Hiraoka Japan 9 76 0.9× 78 1.2× 43 0.7× 74 1.3× 32 1.0× 22 254
Xiaowen Qian China 12 71 0.9× 87 1.3× 65 1.0× 91 1.6× 21 0.7× 42 324
Toshikazu Akioka Japan 9 99 1.2× 35 0.5× 34 0.5× 79 1.4× 31 1.0× 34 264
Elizabeth Brém United States 10 59 0.7× 86 1.3× 36 0.6× 112 1.9× 37 1.2× 35 270
Luděk Pour Czechia 8 51 0.6× 79 1.2× 61 1.0× 69 1.2× 17 0.5× 88 206
Cristina Castilla‐Llorente France 9 77 1.0× 36 0.5× 106 1.7× 70 1.2× 27 0.8× 40 260
Д. С. Абрамов Russia 7 58 0.7× 29 0.4× 33 0.5× 46 0.8× 21 0.7× 56 169
Bella Shadur Australia 10 97 1.2× 65 1.0× 57 0.9× 39 0.7× 35 1.1× 20 214
Colin Phipps Diong Singapore 6 128 1.6× 54 0.8× 46 0.7× 94 1.6× 36 1.1× 23 278
Muriel Picard France 10 61 0.8× 55 0.8× 127 2.0× 67 1.2× 19 0.6× 25 260

Countries citing papers authored by Sameer Melinkeri

Since Specialization
Citations

This map shows the geographic impact of Sameer Melinkeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sameer Melinkeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sameer Melinkeri more than expected).

Fields of papers citing papers by Sameer Melinkeri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sameer Melinkeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sameer Melinkeri. The network helps show where Sameer Melinkeri may publish in the future.

Co-authorship network of co-authors of Sameer Melinkeri

This figure shows the co-authorship network connecting the top 25 collaborators of Sameer Melinkeri. A scholar is included among the top collaborators of Sameer Melinkeri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sameer Melinkeri. Sameer Melinkeri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Seth, Tulika, Sameer Melinkeri, Tuphan Kanti Dolai, et al.. (2025). Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensus. Frontiers in Oncology. 15. 1546641–1546641. 1 indexed citations
2.
3.
Saseedharan, Sanjith, et al.. (2023). Therapeutic Drug Monitoring of Isavuconazole: Lessons Learnt from a Real-life Setting in a Tertiary Care Center in India. Indian Journal of Critical Care Medicine. 27(4). 260–264. 4 indexed citations
4.
Mathews, Vikram, Anu Korula, Anupam Chakrapani, et al.. (2023). Management of B-cell lineage acute lymphoblastic leukemia: expert opinion from an Indian panel via Delphi consensus method. Frontiers in Oncology. 13. 1171568–1171568. 1 indexed citations
5.
Kumar, Lalit, Sameer Melinkeri, Prasanth Ganesan, et al.. (2023). Daratumumab in Indian Patients with Relapsed and Refractory Multiple Myeloma: A Prospective, Multicenter, Phase IV Study. Future Oncology. 20(4). 191–205.
6.
Mahalle, Namita, et al.. (2022). Factors associated with subtherapeutic levels of oral posaconazole tablet: a detailed analysis from a tertiary care center in India. International Journal of Infectious Diseases. 124. 76–80. 3 indexed citations
7.
Singh, Inderjeet, R Swetha, Ronak Patel, et al.. (2021). Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of a Romiplostim Biosimilar in Chronic Refractory Immune Thrombocytopenic Purpura (ITP) Patients. Indian Journal of Hematology and Blood Transfusion. 38(1). 111–121. 4 indexed citations
8.
Damodar, Sharat, et al.. (2020). Correction to: HSCT GUIDELINES FOR TRANSPLANT PRACTICES DURING COVID-19 PANDEMIC IN INDIA. PubMed. 3(2). 59–70. 2 indexed citations
9.
Philip, Joseph, et al.. (2020). Transforming growth factor β1 accelerates and enhances in vitro red blood cell formation from hematopoietic stem cells by stimulating mitophagy. Stem Cell Research & Therapy. 11(1). 71–71. 25 indexed citations
10.
Melinkeri, Sameer, et al.. (2020). Assessment of Knowledge and Practice of Blood Transfusion Among Nurses in a Tertiary Care Hospital in India. Indian Journal of Hematology and Blood Transfusion. 36(2). 393–398. 12 indexed citations
11.
12.
Tiwari, Nishant, et al.. (2020). Anticoagulation in COVID – 19: An Update. SHILAP Revista de lepidopterología. 6(4). 217–223. 8 indexed citations
13.
Melinkeri, Sameer, et al.. (2019). Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients. Frontiers in Immunology. 10. 1079–1079. 11 indexed citations
14.
15.
Melinkeri, Sameer, et al.. (2018). Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy. Scientific Reports. 8(1). 5705–5705. 56 indexed citations
16.
17.
Melinkeri, Sameer, et al.. (2017). Arachidonic acid and Docosahexanoic acid enhance platelet formation from human apheresis-derived CD34+ cells. Cell Cycle. 16(10). 979–990. 11 indexed citations
18.
George, Biju, Vikram Mathews, Kavitha M. Lakshmi, et al.. (2013). The use of a fludarabine‐based conditioning regimen in patients with severe aplastic anemia – a retrospective analysis from three Indian centers. Clinical Transplantation. 27(6). 923–929. 17 indexed citations
19.
Melinkeri, Sameer, Ruchi Gupta, & Sunil Dabadghao. (2002). A Sweet-like syndrome manifesting as gingival hyperplasia and myositis without cutaneous involvement. Annals of Hematology. 81(7). 397–398. 21 indexed citations
20.
Mishra, Saroj Kanta, Sameer Melinkeri, & Sunil Dabadghao. (2001). Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia. European Journal Of Haematology. 67(4). 252–254. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nobuya Hiraoka Breakdown of academic impact, for papers by Xiaowen Qian Breakdown of academic impact, for papers by Toshikazu Akioka Breakdown of academic impact, for papers by Elizabeth Brém Breakdown of academic impact, for papers by Luděk Pour Breakdown of academic impact, for papers by Cristina Castilla‐Llorente Breakdown of academic impact, for papers by Д. С. Абрамов Breakdown of academic impact, for papers by Bella Shadur Breakdown of academic impact, for papers by Colin Phipps Diong Breakdown of academic impact, for papers by Muriel Picard
Rankless by CCL
2026